Derivatization Reagent for Chiral Carnitine Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting D-carnitine content in L-carnitine products are inaccurate, leading to safety concerns and inefficiencies in drug development, as traditional chemical resolution methods fail to completely remove D-isomer, resulting in DL-carnitine contamination, which can cause adverse effects in patients.

Innovation Solution

A stable and easy-to-use optically pure derivatization reagent, (+)α-methyl-6-methoxy-2-naphthyl acetyl chloride, is developed for detecting L-carnitine or D-carnitine, allowing for precise detection using HPLC, with a method involving reaction with the reagent and subsequent chromatographic analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If traditional chemical resolution methods are used for L-carnitine synthesis, then the synthesis process is easy to industrialize and raw materials are cheap, but D-isomer cannot be removed completely resulting in DL-carnitine contamination

Engineering Contradiction:
Improvesynthesis process ease of industrializationVSAvoidoptical purity of L-carnitine
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent introduces an optically pure derivatization reagent as an intermediary substance that selectively reacts with L-carnitine or D-carnitine to form diastereomeric derivatives. This intermediary enables the separation and detection of carnitine isomers by converting the difficult-to-separate enantiomers into easily separable diastereomers through chiral recognition, thereby achieving high optical purity without complex industrial processes

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical parameters of the carnitine molecule by derivatization - converting the amino group of carnitine into a derivative with different physical and chemical properties. This parameter change transforms the detection and separation problem from one involving similar enantiomers to one involving distinguishable diastereomeric derivatives, enabling accurate determination of optical purity

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If specific rotation method is used to detect D-carnitine content, then the detection process is simple, but the detection accuracy is insufficient

Engineering Contradiction:
Improvedetection process simplicityVSAvoidD-carnitine content detection accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent replaces the physical measurement method (specific rotation using polarimetry) with a chemical derivation method followed by chromatographic separation and detection. This substitution uses chemical reactions to create distinguishable derivatives that can be separated and quantified by HPLC, providing much higher measurement precision while maintaining operational simplicity through standardized procedures

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The derivatization reagent acts as a chemical intermediary that enhances the detectability of carnitine isomers. By forming diastereomeric derivatives with different chromatographic retention times, the intermediary enables accurate quantification of D-carnitine content that cannot be achieved by direct physical measurement methods

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If derivatization reagent is prepared as solution, then the reagent is easy to use, but the reagent is unstable during preservation and difficult to preserve

Engineering Contradiction:
Improvereagent ease of useVSAvoidreagent stability during preservation
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent utilizes phase transition by providing the derivatization reagent in solid crystalline form rather than solution form. The solid state provides inherent stability and ease of preservation, while the reagent can be dissolved in appropriate solvents immediately before use to form solutions for derivatization reactions, thus maintaining both stability and ease of operation

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The patent prepares the derivatization reagent in advance in a stable solid form that can be stored for long periods without degradation. The reagent is only converted to solution form when needed for the actual derivatization process, thus preserving stability during storage while maintaining ease of use during operation through simple dissolution procedures

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides high sensitivity and accuracy in detecting L-carnitine or D-carnitine content, ensuring safer pharmaceuticals and health products by effectively differentiating between the isomers, thereby reducing the risk of adverse reactions.

Implementation Method 1

an optically pure derivatization reagent of formula (I) for detecting the content of L-carnitine (or D-carnitine)

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

allowing for precise detection using HPLC

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS8709819B2Preparation and its use of derivatization reagent for detecting L-carnitine or D-carnitine
Publication Date: 2014.04.29 GU SHUHUA
  • US8709819B2 patent drawing
  • US8709819B2 patent drawing
  • US8709819B2 patent drawing

AI summary

A preparation method and its use of derivatization reagent for detecting L-carnitine or D-carnitine are provided. The present reagent is stable. It can be used for detecting L-carnitine or D-carnitine accurately and sensitively. That is to say, the reagent is applied to detecting the amount of synthesized or natural L-carnitine and the amount of mixing D-carnitine. The compound reagent is used for determining the chiral isomers of chemicals, biological reagents, health care reagents, cosmetic, body fluids and various foods, which contain L-carnitine or/and D-carnitine, and optical isomers of other chiral amino acids.